FindMyRecallSubscribe
Class I: serious health riskTerminated

Baxter Healthcare 5% Dextrose Injection Recall

5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Bax…

Baxter Healthcare Corp. · Deerfield, IL

Risk level
Class I
Reported by FDA
Mar 26, 2014
Recall ID
D-1162-2014
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled 5% Dextrose Injection starting Nov 21, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-1162-2014 on Mar 26, 2014. Reason: Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag. Status: Terminated.

Why it was recalled

Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag

Product description

5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.

Lot numbers, UPCs & expiration codes

Lot #: P285288, Exp 11/13

Where it was sold

Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1162-2014
Classification
Class I
Status
Terminated
Recall initiated
Nov 21, 2013
FDA report date
Mar 26, 2014
Quantity
105,216 containers
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corp.

Original FDA data

Every field from FDA enforcement report D-1162-2014, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Terminated
Country
United States
Event ID
67092
Address
1 Baxter Pkwy
Code information
Lot #: P285288, Exp 11/13
Postal code
60015-4625
Report date
Mar 26, 2014
Product type
Drugs
Recall number
D-1162-2014
Classification
Class I
Recalling firm
Baxter Healthcare Corp.
Product quantity
105,216 containers
Termination date
Sep 21, 2016
Reason for recall
Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
Voluntary / mandated
Voluntary: Firm initiated
Product description
5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.
Distribution pattern
Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.
Recall initiation date
Nov 21, 2013
Initial firm notification
Letter
Center classification date
Mar 14, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1162-2014, published Mar 26, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls